J. Bueren

发表

Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells

J. Segovia, J. Bueren, M. Lamana, 2001, The journal of gene medicine.

In vitro myelosuppressive effects of the parvovirus minute virus of mice (MVMi) on hematopoietic stem and committed progenitor cells.

J. Almendral, J. Bueren, J. Segovia, 1991, Blood.

In vitro and in vivo expression of human erythrocyte pyruvate kinase in erythroid cells: a gene therapy approach.

J. Segovia, A. Díez, J. Bautista, 2007, Human gene therapy.

Functional analysis of gammaretroviral vector transduction by quantitative PCR

A. Díez, J. Bautista, O. Quintana-Bustamante, 2006, The journal of gene medicine.

Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors.

D. Curiel, J. Gómez-Navarro, F. Garcia-sanchez, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Conclusions of a national multicenter intercomparative study of in vitro cultures of human hematopoietic progenitors

M. Lamana, J. Bueren, B. Albella, 1999, Bone Marrow Transplantation.

Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells

Á. Ramírez, P. Río, J. Bueren, 2005, Gene Therapy.

Does the granulocyte-macrophage colony-forming unit content in ex vivo-expanded grafts predict the recovery of the recipient leukocytes?

J. Bueren, B. Albella, J. Segovia, 1997, Blood.

Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer

A. Balas, M. Lamana, J. Bueren, 2004, Gene Therapy.

Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.

I. Pragnell, G. Guenechea, J. Bueren, 1999, Transplantation.

Therapeutic gene editing in hematopoietic progenitor cells from a mouse model of Fanconi anemia

J. Surrallés, S. Rodríguez-Perales, T. Cathomen, 2018, bioRxiv.

Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain i)

J. Almendral, J. Bueren, J. Segovia, 1995, Journal of virology.

Transplantation of syngenic bone marrow contaminated with NGFr-marked WEHI-3B cells: an improved model of leukemia relapse in mice

J. García-Castro, J. Bueren, J. Segovia, 2000, Leukemia.

Latent hematopoietic stem cell toxicity associated with protracted drug administration.

R. Parchment, J. Bueren, B. Albella, 2001, Experimental hematology.

Safety of retroviral gene marking with a truncated NGF receptor

A. Hagenbeek, E. Weissinger, J. Falkenburg, 2003, Nature Medicine.

Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy

Á. Raya, J. Segovia, J. Bueren, 2014, Stem cells.

Restored Hematopoietic Stem Cell Transcriptional Program in Fanconi Anemia Patients Following Gene Therapy

F. Prósper, D. Gómez-Cabrero, N. Planell, 2021, medRxiv.

Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model

F. Garcia-sanchez, J. García-Castro, P. Río, 2003, Gene Therapy.

In vitro and in vivo susceptibility of mouse megakaryocytic progenitors to strain i of parvovirus minute virus of mice.

M. Lamana, J. Bueren, B. Albella, 2001, Experimental hematology.